Premal Thaker, MD
Enriched profileDirector of the Division of Gynecologic Oncology, David & Lynn Mutch Distinguished Professor of Obstetrics and Gynecology · Washington University School of Medicine in St. Louis
Premal Thaker is Director of the Division of Gynecologic Oncology, David & Lynn Mutch Distinguished Professor of Obstetrics and Gynecology at Washington University School of Medicine in St. Louis. OpenAlex indexes 785 publications with 10,999 citations (h-index 50); ClinicalTrials.gov lists 20 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Gynecologic Oncology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Premal Thaker, MD, is Director of the Division of Gynecologic Oncology, David & Lynn Mutch Distinguished Professor of Obstetrics and Gynecology at Washington University School of Medicine in St. Louis. The public record shows 785 publications with 10,999 citations (h-index 50), centered on Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, BRCA gene mutations in cancer. It also documents an investigator role on 20 registered clinical trials, industry payments reported by 29 companies, 2 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · Cancer research
- Top research focus: Ovarian cancer diagnosis and treatment
- 20 registered trials on ClinicalTrials.gov
- Open Payments reporting from 29 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 174.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 20 registered studies on ClinicalTrials.gov. The most recent:
- Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Sponsor: Washington University School of Medicine
Industry payments
Updated 18 Oct 2026
29 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20258 payments$18,805openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year202516 payments
- Corcept TherapeuticsProgram year20256 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
66.7%Corticosteroid66.7%Dexamethasone sodium phosphate95%Dexamethasone5%Part D + Part B≥25 patientsNervous system
15%Gabapentinoids3.8%Gabapentin72%Pregabalin28%Part D<11 patientsOpioid Agonist3.3%Oxycodone Hcl63%Oxycodone-Acetaminophen37%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
3.4%Serotonin-3 Receptor Antagonist3.4%Ondansetron Hcl100%Part D≥27 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
2 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- WASHINGTON UNIVERSITY / SITEMAN CANCER CENTER LEAD ACADEMIC SITE
Washington University
FY2026$2,071,012UG1CA233339 - Washington University/Siteman Cancer Center Lead Academic Site
Washington University
FY2025$1,239,849UG1CA233339 - Washington University/Siteman Cancer Center Lead Academic Site
Washington University
FY2024$1,241,704UG1CA233339
Congress activity
Updated 18 Oct 2026
80 congress contributions (2006–2026) across AACR, ADA, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Azenosertib plus paclitaxel for platinum-resistant ovarian cancer: Results from a phase 1b study.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Journal of clinical oncology
Clinical Trial2025 - Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study.
International journal of gynecological cancer
Article2024 - Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins.
Molecular cancer research
Article2023
Most-cited works
by citation count (OpenAlex)- 01Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaArticle1,317 citations2006
- 02Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerArticle763 citations2023
- 03Stress Hormone–Mediated Invasion of Ovarian Cancer CellsArticle487 citations2006
- 04NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Article402 citations2022
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
obgyn.wustl.edu/gynecologic-oncology-chief-dr-premal-thaker-joins-fpp-board-of-directors
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →obgyn.wustl.edu ↗ - Other
ovarcome.transistor.fm/episodes/transforming-treatment-in-ovarian-cancer-breakthroughs-offering-hope
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ovarcome.transistor.fm ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →siteman.washu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →siteman.washu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connect.medicalnewstoday.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connect.medicalnewstoday.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obgyn.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obgyn.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →source.washu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obgyn.wustl.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obgyn.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obgyn.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obgyn.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →source.washu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →source.washu.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ovarcome.transistor.fm ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramaswamy Govindan, MD
Washington University School of Medicine in St. Louis
Marin Kollef, MD
Washington University School of Medicine in St. Louis
Mark Huffman, MD
Washington University School of Medicine in St. Louis
Ravi Vij, MD
Washington University School of Medicine in St. Louis
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute